PFM Health Sciences’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.8M | Buy |
+178,319
| New | +$9.8M | 0.83% | 34 |
|
|
2023
Q4 | – | Sell |
-498,280
| Closed | -$44.1M | – | 67 |
|
|
2023
Q3 | $44.1M | Buy |
498,280
+147,982
| +42% | +$13.1M | 2.08% | 19 |
|
|
2023
Q2 | $30.4M | Buy |
350,298
+190,732
| +120% | +$16.5M | 1.18% | 37 |
|
|
2023
Q1 | $15.5M | Sell |
159,566
-150,835
| -49% | -$14.7M | 0.69% | 47 |
|
|
2022
Q4 | $32.1M | Sell |
310,401
-805,548
| -72% | -$83.4M | 1.15% | 34 |
|
|
2022
Q3 | $94.6M | Buy |
1,115,949
+276,578
| +33% | +$23.4M | 3.42% | 3 |
|
|
2022
Q2 | $69.6M | Buy |
839,371
+120,876
| +17% | +$10M | 2.65% | 11 |
|
|
2022
Q1 | $55.4M | Buy |
718,495
+253,555
| +55% | +$19.5M | 2.07% | 15 |
|
|
2021
Q4 | $41.1M | Buy |
+464,940
| New | +$41.1M | 1.4% | 36 |
|
|
2021
Q1 | – | Sell |
-314,499
| Closed | -$27.6M | – | 80 |
|
|
2020
Q4 | $27.6M | Sell |
314,499
-385,553
| -55% | -$33.8M | 0.97% | 35 |
|
|
2020
Q3 | $53.3M | Buy |
700,052
+216,973
| +45% | +$16.5M | 2.46% | 8 |
|
|
2020
Q2 | $59.6M | Buy |
483,079
+83,474
| +21% | +$10.3M | 3.09% | 5 |
|
|
2020
Q1 | $33.8M | Sell |
399,605
-154,029
| -28% | -$13M | 2.77% | 14 |
|
|
2019
Q4 | $46.8M | Sell |
553,634
-1,595,417
| -74% | -$135M | 2.23% | 15 |
|
|
2019
Q3 | $145M | Buy |
2,149,051
+69,663
| +3% | +$4.7M | 4.28% | 2 |
|
|
2019
Q2 | $178M | Buy |
+2,079,388
| New | +$178M | 3.38% | 2 |
|
|
2017
Q3 | – | Sell |
-153,018
| Closed | -$13.9M | – | 84 |
|
|
2017
Q2 | $13.9M | Sell |
153,018
-830,108
| -84% | -$75.4M | 0.37% | 65 |
|
|
2017
Q1 | $86.3M | Sell |
983,126
-74,433
| -7% | -$6.53M | 2.16% | 12 |
|
|
2016
Q4 | $87.6M | Buy |
1,057,559
+334,821
| +46% | +$27.7M | 2.47% | 5 |
|
|
2016
Q3 | $66.9M | Buy |
722,738
+151,634
| +27% | +$14M | 1.96% | 15 |
|
|
2016
Q2 | $44.4M | Buy |
+571,104
| New | +$44.4M | 1.34% | 28 |
|